23andMe has reached an $18 million settlement after a coalition of 42 states including Alabama filed claims seeking damages for a 2023 data breach that jeopardized the personal data of 6.9 million ...
Virginia Attorney General Jay Jones joined a coalition of 42 attorneys general announcing a settlement with the bankruptcy ...
Opinion
9don MSNOpinion
‘The company failed to implement basic defenses’: 23andMe data breach victims are finally getting paid, but bankruptcy could shrink their payouts
The settlement highlights the lasting risks of exposing genetic data that can’t be changed or replaced.
Utah and over 40 other states on Wednesday announced a $18 million settlement agreement with genetic information company ...
The bidding competition over 23andMe may not be over. The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, saying she ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...
Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.
Companies have a duty to protect their customers’ personal information from hackers, but 23andMe put millions of its customers at risk with its flimsy security measures,” J ...
A nonprofit controlled by Anne Wojcicki, former chief executive of 23andMe, has won the bidding process to buy the bankrupt genetic testing company. If approved by the court, the sale would put ...
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its ...
With a purchase price of $256 million, some investors might think the valuation is a bit rich for a business in such a dire position as 23andMe, but it won't put a huge dent into Regeneron's ...
A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Abigail Adams is a Human Interest Writer-Reporter for PEOPLE. Justin Sullivan/Getty; Michael Nagle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results